88IV - Public company info - Shanghai Bio-heart Biological Technology Co. Ltd.

Input the stock code or the company name

Shanghai Bio-heart Biological Technology Co. Ltd. - H Shares, 02185.HK - Cash Flow	2022-12	2021-12	2020-12	2019-12
Net Cash Flow from Operating Activities	-140,616	-88,471	-48,494	-21,361
Net Cash Flow from Return on Investments & Servicing of Finance	4,010	972	190	8
Interest Received	4,010	972	190	8
Interest Paid	0	0	0	0
Dividend Received	0	0	0	0
Dividend Paid	0	0	0	0
Others	0	0	0	0
Taxes (Paid) / Refunded	0	0	0	0
Net Cash Flow from Investing Activities	-104,696	-34,704	-225,341	-5,668
Additions to Fixed Assets	-30,038	-34,274	-5,747	-14,989
Disposal of Fixed Assets	0	0	0	0
Increase in Investments	-74,658	0	-220,417	0
Decrease in Investments	0	0	0	0
Net Cash Flow with Related Parties	0	0	713,534	43,813
Others	0	-430	-712,711	-34,492
Net Cash Flow before Financing Activities	-241,302	-122,203	-273,645	-27,021
Net Cash Flow from Financing Activities	-35,178	383,680	722,993	43,090
New Loans	0	0	0	0
Loans Repayment	-3,594	-4,292	-1,167	-723
Fixed Income/Debt Instruments	0	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0	0
Equity Financing	0	395,246	14,509	0
Net Cash Flow with Related Parties	0	0	713,534	43,813
Others	-31,584	-7,274	-3,883	0
Increase(Decrease) in Cash & Cash Equivalents	-276,480	261,477	449,348	16,069
Cash & Cash Equivalents at Beginning of Year	708,531	453,667	20,672	4,595
Net Cash Flow due to Change in Exchange Rate/Others	19,267	-6,613	-16,353	8
Cash & Cash Equivalents at End of Year	451,318	708,531	453,667	20,672
Currency	Renminbi	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	1	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Shanghai Bio-heart Biological Technology Co. Ltd. - H Shares , 02185.HK